| Alert | Date Issued |
|---|
| CDC Health Advisory: Nationwide Shortage of Doxycycline - Resources for Providers and Recommendations for Patient Care | 06/17/2013 |
| CDC Health Update: Updated Guidelines for Evaluation of Severe Respiratory Illness Associated With Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | 06/12/2013 |
| DOHMH Alert #15: Update on Measles in NYC - New Vaccine Recommendations | 06/05/2013 |
| DOHMH Alert #14: Ricin-Contaminated Letter Sent to City Hall Mail Facility | 05/31/2013 |
| DOHMH Alert #13: Severe Acute Respiratory Illness in Returning Travelers | 05/29/2013 |
| DOHMH Alert #12: Update on Measles in New York City | 05/23/2013 |
| Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials | 05/21/2013 |
| Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result | 05/20/2013 |
| Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion | 05/7/2013 |
| Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution | 05/7/2013 |
| Eba Multivitamin Supplement By Saratoga Therapeutics LLC: Recall - Allergy Alert On Undeclared Milk Components | 05/7/2013 |
| Sodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall - Particulate Matter | 05/7/2013 |
| Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches | 05/7/2013 |
| Potiga (Ezogabine): Drug Safety Communication - Linked To Retinal Abnormalities And Blue Skin Discoloration | 04/29/2013 |
| LifeScan, Inc. OneTouch Verio IQ Blood Glucose Meter - Class I Recall: Failure to Provide a Warning at Extremely High Blood Glucose Levels | 04/24/2013 |
| FDA approves abuse-deterrent labeling for reformulated OxyContin. Agency will not approve generics to original OxyContin | 04/17/2013 |
| DOHMH Alert #9: Measles in New York City | 04/16/2013 |
| URGENT PRODUCT RECALL -FreeStyle InsuLinx Blood Glucose Meter | 04/16/2013 |
| Medicines in My Home Update: Safe Disposal of Fentanyl Transdermal System “Patches” | 04/16/2013 |
| Important information for patients: Voluntary recall of LEVOXYL | 04/11/2013 |
| DOHMH Alert #8: Update: Exposure to Hepatitis A in Patrons of Alta Restaurant | 04/09/2013 |
| DOHMH Alert #7: Update: Neonatal Herpes Infection Following Ritual Jewish Circumcision | 04/09/2013 |
| Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection | 03/20/2013 |
| Medication Safety link on Acetaminophen for your patients | 03/19/2013 |
| Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas | 03/18/2013 |
| DOHMH Alert #5: Invasive Meningococcal Disease in Men Who Have Sex with Men, Four New Cases Reported in 2013, Expanded Vaccine Recommendations | 03/15/2013 |
| Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms | 03/13/2013 |
| Omontys (peginesatide) Injection by Affymax and Takeda: Recall of All Lots - Serious Hypersensitivity Reactions | 02/28/2013 |
| Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter | 02/20/2013 |
| Register To Receive City Health Information Bulletins | 02/04/2013 |
| Recommendations for Drug Allocation, Tuberculosis Prevention and Patient Care During Isoniazid Shortages | 01/30/2013 |
| Summary of CDC Recommendations for Influenza Antiviral Medications | 01/30/2013 |
| Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility | 01/30/2013 |
| Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury | 01/25/2013 |
| Ferrous Sulfate Tablets, 325 mg Labeled as Rugby Natural Iron Supplement: Recall - Bottle May Contain Meclizine HCl 25 mg Tablets | 01/22/2013 |
| Executive Order Allows Pharmacists in New York State to Vaccinate Children Ages 6 Months to 18 Years | 01/16/2013 |
| NYSDOH Authorizes Use of Influenza Vaccines Containing Thimerosal | 01/16/2013 |
| Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile | 01/11/2013 |
| Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses | 01/11/2013 |
| DOHMH 2013 Advisory #2 - NYC Influenza Update | 01/10/2013 |
| DOHMH 2013 Alert #1 - Neonatal Herpes | 01/10/2013 |
| Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets | 01/02/2013 |
| Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Should Not Be Used in Patients with Mechanical Prosthetic Heart Valves | 12/20/2012 |
| Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions | 12/20/2012 |
| Xyrem (sodium oxybate): Drug Safety Communication - Warning Against Use With Alcohol or Drugs Causing Respiratory Depression | 12/18/2012 |
| DOHMH 2012 Advisory # 38- Influenza Advisory | 12/18/2012 |
| Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified | 12/17/2012 |
| Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets | 12/07/2012 |
| Ondansetron (Zofran) 32 mg, Single Intravenous (IV) Dose: Updated Safety Communication – Product Removal due to Potential For Serious Cardiac Risk | 12/05/2012 |
| Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance |
11/29/2012 |
| Manufacturer Initiates Nationwide Voluntary, Patient Level Recall for One Lot of Pradaxa® |
11/20/2012 |
| Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events |
11/16/2012 |
| CDC Advisory - Voluntary Recall of All Ameridose Medical Products |
11/16/2012 |
| DOHMH Alert # 30 - UPDATE: Invasive Meningococcal Disease in Men Who Have Sex with Men |
11/14/2012 |
| DOHMH Alert #30 - UPDATE: Invasive Meningococcal Disease in Men Who Have Sex With Men |
10/29/2012 |
| FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised |
10/19/2012 |
| Hospira Lactated Ringer’s And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination |
10/19/2012 |
| Update: Multistate Outbreak of Meningitis and Stroke Associated with Potentially Contaminated Steroid Medication |
10/11/2012 |
| New York State Department of Health Statement on Multistate Fungal Meningitis Outbreak |
10/10/2012 |
| 2012 ALERT # 28
UPDATE: Meningococcal Vaccine Recommendations for HIV-infected
Men Who Have Sex with Men |
10/09/2012 |
| DOHMH Alert #27 - Invasive Meningococcal Disease in Men Who Have Sex with Men |
10/03/2012 |
| Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and Superpotent Tablets |
09/24/2012 |
| Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure |
09/19/2012 |
| Qualitest Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets |
09/13/2012 |
| Nimodipine: Recall - Crystallization of Fill Material |
09/05/2012 |
| Revatio (sildenafil): Drug Safety Communication - Recommendation Against Use in Children |
09/05/2012 |
| Pesticide Spraying Notification |
08/14/2012 |
| Increase in Influenza A H3N2v Virus Infections in Three U.S. States |
08/07/2012 |
| First Human Case of West Nile Viral Disease in NYC |
08/07/2012 |
| Drug Safety Communication - Seizure Risk for Multiple Sclerosis Patients |
07/25/2012 |
| 22012 DOHMH Advisory #14: Tick-borne Disease Advisory |
07/18/2012 |
| 2012 DOHMH Advisory #8: West Nile Virus |
07/17/2012 |
| Testing and Reporting Guidelines for Cases of Viral Encephalitis and Meningitis,
West Nile and other Arboviral Infections |
07/17/2012 |
| iFlora Kids Multi-Probiotic and iFlora 4-Kids Powder Dietary Supplements: Recall - Possible Salmonella Contamination |
07/13/2012 |
| Ondansetron (Zofran) IV: Drug Safety Communication - QT Prolongation |
07/13/2012 |
| Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter |
07/13/2012 |
| Use of Azithromycin to Treat STDs |
07/02/2012 |
| HIV/AIDS Resources Available for Your Patients |
06/25/2012 |
| Podcasts on Medication Management |
06/21/2012 |
| Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw |
06/11/2012 |
| Teva’s Adderall 30-mg Tablets: Counterfeit Product — Contains Wrong Active Ingredients |
05/31/2012 |
| Reimbursement for Smoking Cessation: New Tools From the NYS Smokers’ Quitline |
05/25/2012 |
| Falls In Older Adults: Statistics and Prevention |
05/15/2012 |
| FDA Warning: Avoid Use of Aliskiren-Containing Drugs With ACEIs or ARBs in Patients With Diabetes or Renal Impairment |
04/23/2012 |
| Altuzan (bevacizumab): Counterfeit Product - Contains No Active Ingredient |
04/05/2012 |
| Bedford Labs Recalls Three Lots of Cytarabine for Injection, 1 gm/vial — Potential Lack of Sterility |
2/29/2012 |
| American Regent Recalls Lot #0693 of Phenylephrine HCl Injection, 1%, 5-mL Vial — Visible Particles |
2/29/2012 |
| Glenmark Generics Recalls Seven Lots of Birth Control Pills — Possibility of Out-of-Sequence Tablets |
2/29/2012 |
| DOH: Sign Up to Receive the New and Improved Electronic Version of City Health Information |
2/22/2012 |
| DOH Advisory: Animal Rabies in NYC in 2011 |
2/22/2012 |
| Proton Pump Inhibitors May Increase Risk of Clostridium Difficile-Associated Diarrhea |
2/17/2012 |
| NYC DOH Alert: Neisseria gonorrhoeae Isolates With Reduced Susceptibility to Cephalosporins |
2/15/2012 |
| Novartis Recalls Over-the-Counter Excedrin, Bufferin, Gas-X Prevention and NoDoz |
1/23/2012 |
| DOH Advisory: Cronobacter sakazakii Infections in Newborns |
1/03/2012 |
| City Health Information: Preventing Misuse of Prescription Opioid Drugs |
12/29/2011 |
| 2011 Advisory #28: Health Department Releases New Opioid Prescribing Gridance |
12/29/2011 |
| Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose |
12/28/2011 |
| Novartis Halts ALTITUDE Study of Aliskiren in Combination with ACE Inhibitor or ARB: Increased Risk of Adverse Events |
12/28/2011 |
| Rise in Pertussis Cases in New York City |
12/28/2011 |
| FDA: Unclear Link Between SSRI Use During Pregnancy and Persistent Pulmonary Hypertension of the Newborn | 12/21/2011 |
| NYC DOHMH Releases New HIV Treatment Recommendations | 12/5/2011 |
| TNF Blockers May Increase Risk of Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults | 11/10/2011 |
| Trilipix Label Change: May Not Reduce Heart Attack or Stroke Risk | 11/10/2011 |
| Xigris Voluntarily Withdrawn From Market - No Survival Benefit | 10/27/2011 |
| Zyvox Warning: Serious CNS Reactions When Taken With an SSRI or SNRI | 10/24/2011 |
| Methylene Blue Warning: Serious CNS Reactions When Taken With Certain Psychiatric Drugs | 10/24/2011 |
| Sprycel Associated With Increased Risk of Pulmonary Arterial Hypertension | 10/13/2011 |
| Increase in Legionnaires’ Disease in the Bronx | 10/06/2011 |
| Qualitest Pharmaceuticals Issues Nationwide Voluntary Recall of Oral Contraceptives | 09/19/2011 |
| Zofran (ondansetron) Associated with Increased Risk of Abnormal Heart Rhythms | 09/19/2011 |
| DOHMH Advisory: Human Cases of West Nile Viral Disease in NYC | 09/06/2011 |
| FDA Alert: Serious Allergic Reactions With Saphris | 09/06/2011 |
